Umbilical Cord Mesenchymal Stem Cell Therapy (Asia Stem Cell Regenerative)

脐带间充质干细胞疗法(亚洲干细胞再生)

Report date: 2023/11/24 20:10:21

Base Information

Drug NameUmbilical Cord Mesenchymal Stem Cell Therapy (Asia Stem Cell Regenerative)
Drug Alias NameUC-MSC
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsMyocardial IschemiaLiver CirrhosisSpondylitis, Ankylosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaClinical
Originator CompaniesAsia Stem Cell Regenerative Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAsia Stem Cell Regenerative Pharmaceutical Co LtdAsia Cell Therapeutics (Shanghai) Co LtdUniversity Of Miami +[4] 
Inactive CompaniesN/A
Active IndicationsMyocardial IschemiaLiver CirrhosisSpondylitis, Ankylosing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A